Your prediction
InMed Pharmaceuticals Inc. Stock
InMed Pharmaceuticals Inc. dominated the market today, gaining €0.033 (15.290%).
For the coming years our community has positive and negative things to say abot the InMed Pharmaceuticals Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Innovation" there were negative voices in the community.
Pros and Cons of InMed Pharmaceuticals Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of InMed Pharmaceuticals Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
InMed Pharmaceuticals Inc. | 15.290% | -8.068% | -21.725% | -77.523% | -28.779% | -99.669% | -99.901% |
Promis Neurosciences Inc. | 1.750% | -2.247% | 11.538% | -76.644% | 74.874% | -73.874% | -82.530% |
Resverlogix Corp | - | 0.000% | 8.955% | -61.780% | -15.116% | -93.866% | -98.608% |
Aurinia Pharmaceuticals Inc. | 4.310% | 1.488% | 2.909% | -53.186% | -41.411% | -56.748% | -13.948% |